Difference 79000000 exceeds tolerance 21208000.000. Presentation or filing-vintage differences need review.
IQVIA HOLDINGS INC. (IQV) reported revenue of $16.31B and net income of $1.36B for the fiscal year ended 2025-12-31. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from IQVIA HOLDINGS INC.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Services-Commercial Physical & Biological Research.
Income
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $16.31B | $15.40B | $14.98B | $14.41B | $13.87B | $11.36B | $11.09B | $10.41B | $9.70B | $6.82B |
| Cost of revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Gross profit | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Operating income | $2.18B | $2.20B | $1.98B | $1.80B | $1.39B | $731.00M | $777.00M | $741.00M | $665.00M | $576.00M |
| Net income | $1.36B | $1.37B | $1.36B | $1.09B | $966.00M | $279.00M | $191.00M | $259.00M | $1.28B | $72.00M |
| Research & development | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Weighted-average diluted shares | shares 173.50M | shares 183.40M | shares 186.30M | shares 190.60M | shares 195.00M | shares 195.00M | shares 199.60M | shares 208.20M | shares 222.60M | shares 152.00M |
| Pretax income | $1.59B | $1.67B | $1.46B | $1.36B | $1.13B | $373.00M | $352.00M | $328.00M | $294.00M | $416.00M |
| Income tax expense | $252.00M | $301.00M | $101.00M | $260.00M | $163.00M | $72.00M | $116.00M | $59.00M | -$992.00M | $325.00M |
| Diluted EPS | $7.84 | $7.49 | $7.29 | $5.72 | $4.95 | $1.43 | $0.96 | $1.24 | $5.74 | $0.47 |
| Selling, general & administrative | $2.00B | $1.99B | $2.05B | $2.07B | $1.96B | $1.79B | $1.73B | $1.72B | $1.62B | $1.02B |
| General & administrative | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Selling & marketing | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Balance
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $1.98B | $1.70B | $1.38B | $1.22B | $1.37B | $1.81B | $837.00M | $891.00M | $959.00M | $1.20B |
| Total assets | $29.94B | $26.90B | $26.68B | $25.34B | $24.69B | $24.56B | $23.25B | $22.55B | $22.86B | $21.21B |
| Current assets | $6.25B | $5.83B | $5.60B | $4.98B | $4.76B | $5.09B | $4.13B | $3.87B | $3.55B | $3.34B |
| Total liabilities | $23.31B | $20.83B | $20.57B | $19.57B | $18.65B | $18.28B | $16.99B | $15.60B | $14.61B | $12.35B |
| Current liabilities | $8.34B | $6.96B | $6.49B | $5.58B | $5.24B | $4.56B | $3.94B | $3.53B | $3.16B | $2.70B |
| Total equity incl. NCI | $6.63B | $6.07B | $6.11B | $5.76B | $6.04B | $6.28B | $6.26B | $6.95B | $8.24B | $8.78B |
| Temporary (mezzanine) equity | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Inventory | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Accounts receivable | $3.40B | $3.20B | $3.38B | $2.92B | $2.55B | $2.41B | $2.58B | $2.39B | $2.10B | $1.71B |
| Goodwill | $16.62B | $14.71B | $14.57B | $13.92B | $13.30B | $12.65B | $12.16B | $11.80B | $11.85B | $10.73B |
| Long-term debt | $13.88B | $12.84B | $12.96B | $12.60B | $12.03B | $12.38B | $11.54B | $10.91B | $10.12B | $7.11B |
| Accounts payable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | $437.00M | $322.00M | $250.00M |
Cash flow
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $2.65B | $2.72B | $2.15B | $2.26B | $2.94B | $1.96B | $1.42B | $1.25B | $970.00M | $860.00M |
| Capital expenditures | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Investing cash flow | -$2.30B | -$1.44B | -$1.60B | -$2.01B | -$2.10B | -$796.00M | -$1.19B | -$810.00M | -$1.19B | $1.73B |
| Financing cash flow | -$150.00M | -$878.00M | -$382.00M | -$329.00M | -$1.24B | -$217.00M | -$276.00M | -$452.00M | -$72.00M | -$2.28B |
| Net change in cash | $278.00M | $326.00M | $160.00M | -$150.00M | -$448.00M | $977.00M | -$54.00M | -$68.00M | -$239.00M | $221.00M |
| Stock-based compensation | $247.00M | $206.00M | $217.00M | $194.00M | $170.00M | $95.00M | $146.00M | $113.00M | $106.00M | $106.00M |
| Common dividends paid | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Common share repurchases | $1.24B | $1.35B | $992.00M | $1.17B | $406.00M | $447.00M | $949.00M | $1.40B | $2.62B | $1.10B |
| Depreciation & amortization | $1.14B | $1.11B | $1.12B | $1.13B | $1.26B | $1.29B | $1.20B | $1.14B | $1.01B | $289.00M |
Derived
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Free cash flow | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Gross margin | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Operating margin | 13.4% | 14.3% | 13.2% | 12.5% | 10.0% | 6.4% | 7.0% | 7.1% | 6.9% | 8.5% |
| FCF margin | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| SBC / revenue | 1.5% | 1.3% | 1.4% | 1.3% | 1.2% | 0.8% | 1.3% | 1.1% | 1.1% | Unavailable |
| Current ratio | 0.75x | 0.84x | 0.86x | 0.89x | 0.91x | 1.12x | 1.05x | 1.10x | 1.13x | 1.23x |
| Revenue YoY growth | 5.9% | 2.8% | 4.0% | 3.9% | 22.1% | 2.4% | 6.5% | 7.3% | 42.4% | Unavailable |
| Net margin | 8.3% | 8.9% | 9.1% | 7.6% | 7.0% | 2.5% | 1.7% | 2.5% | 13.2% | 1.1% |
| R&D / revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| CapEx / revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Long-term debt / equity | 2.09x | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Effective tax rate | 15.8% | 18.0% | 6.9% | 19.1% | 14.5% | 19.3% | 33.0% | 18.0% | -337.4% | 78.1% |
Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open IQV in the interactive workspace to inspect any figure back to its filing.
Source filings
Reconciliation checks needing review
1 period on this page do not reconcile under this site’s normalization. Read that as a limitation here before an observation about the company: the figures are the filer’s own, the filings linked above are authoritative, and a difference usually means the concepts this site selected do not match how this filer presents its statements. Nothing is adjusted to make a check pass.